JPRN-UMIN000018233已完成2 期
Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer. - Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Brain metastasis with the symptom 2)Active interstitial pneumonia or pulmonary fibrosis 3)Body fluid retention to need waste fluid 4)Hypersensitivity for paclitaxel or albumin 5)Pregnant or nursing female or man without the intention of the contraception 6)Active concomitant malignancy 7)Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
不适用
Phase II study of nab-paclitaxel in patients with previously treated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012114Osaka City General Hospital30
招募中
不适用
Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000014558Tottori University Faculty of Medicine27
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22